Alzheimer's drug lecanemab hailed as momentous breakthrough

Alzheimer's drug lecanemab hailed as momentous breakthrough External link

The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous. The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.

Tagsalzheimer'smedicine
Content typeLINK